Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Coghlan

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Rheumatology (Oxford, England)|July 18, 2023
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysisOliver Distler, Christian Ofner, Dörte Huscher, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
Nature Communications|November 26, 2022
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2022
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial HypertensionRowena J Jones, Eckart M D D De Bie, Emily Groves, et al.
Circulation|October 4, 2017
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Marta Bleda, Matthias Haimel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Loss-of-Function ABCC8 Mutations in Pulmonary Arterial HypertensionMichael S Bohnen, Lijiang Ma, Na Zhu, et al.
Journal of Clinical Medicine|May 17, 2020
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD RegistryHarald Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Rheumatology (Oxford, England)|July 18, 2023
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysisOliver Distler, Christian Ofner, Dörte Huscher, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
Nature Communications|November 26, 2022
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2022
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial HypertensionRowena J Jones, Eckart M D D De Bie, Emily Groves, et al.
Circulation|October 4, 2017
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Marta Bleda, Matthias Haimel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Loss-of-Function ABCC8 Mutations in Pulmonary Arterial HypertensionMichael S Bohnen, Lijiang Ma, Na Zhu, et al.
Journal of Clinical Medicine|May 17, 2020
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD RegistryHarald Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Pageof 11